Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Lang I, Füllsack S, Wyzgol A, Fick A, Trebing J, Arana JA, Schäfer V, Weisenberger D, Wajant H.

J Biol Chem. 2016 Mar 4;291(10):5022-37. doi: 10.1074/jbc.M115.683946. Epub 2015 Dec 31.

PMID:
26721880
2.

Principles of antibody-mediated TNF receptor activation.

Wajant H.

Cell Death Differ. 2015 Nov;22(11):1727-41. doi: 10.1038/cdd.2015.109. Epub 2015 Aug 21. Review.

3.

Macromolecular X-ray structure determination using weak, single-wavelength anomalous data.

Bunkóczi G, McCoy AJ, Echols N, Grosse-Kunstleve RW, Adams PD, Holton JM, Read RJ, Terwilliger TC.

Nat Methods. 2015 Feb;12(2):127-30. doi: 10.1038/nmeth.3212. Epub 2014 Dec 22.

4.

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy.

Schaer DA, Hirschhorn-Cymerman D, Wolchok JD.

J Immunother Cancer. 2014 Apr 15;2:7. doi: 10.1186/2051-1426-2-7. eCollection 2014. Review.

5.

Secreted and transmembrane 1A is a novel co-stimulatory ligand.

Howie D, Garcia Rueda H, Brown MH, Waldmann H.

PLoS One. 2013 Sep 10;8(9):e73610. doi: 10.1371/journal.pone.0073610. eCollection 2013.

6.

Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjögren's syndrome.

Gan X, Feng X, Gu L, Tan W, Sun X, Lv C, Zhang M.

Clin Dev Immunol. 2013;2013:340751. doi: 10.1155/2013/340751. Epub 2013 Jul 7.

7.

Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.

Tian J, Ma J, Ma K, Ma B, Tang X, Baidoo SE, Tong J, Yan J, Lu L, Xu H, Wang S.

PLoS One. 2012;7(10):e46936. doi: 10.1371/journal.pone.0046936. Epub 2012 Oct 15.

8.

Analysis of domain-swapped oligomers reveals local sequence preferences and structural imprints at the linker regions and swapped interfaces.

Shingate P, Sowdhamini R.

PLoS One. 2012;7(7):e39305. doi: 10.1371/journal.pone.0039305. Epub 2012 Jul 27.

9.

Modulation of GITR for cancer immunotherapy.

Schaer DA, Murphy JT, Wolchok JD.

Curr Opin Immunol. 2012 Apr;24(2):217-24. doi: 10.1016/j.coi.2011.12.011. Epub 2012 Jan 12. Review.

10.

Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.

Nocentini G, Ronchetti S, Petrillo MG, Riccardi C.

Br J Pharmacol. 2012 Apr;165(7):2089-99. doi: 10.1111/j.1476-5381.2011.01753.x. Review.

11.

The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Twohig JP, Cuff SM, Yong AA, Wang EC.

Rev Neurosci. 2011;22(5):509-33. doi: 10.1515/RNS.2011.041. Epub 2011 Aug 24. Review.

12.

Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.

Placke T, Kopp HG, Salih HR.

Clin Dev Immunol. 2010;2010:239083. doi: 10.1155/2010/239083. Epub 2010 Sep 26. Review.

13.

An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand.

Cui D, Wang S, Chen Y, Tong J, Ma J, Tang L, Yang X, Shi Y, Tian J, Lu L, Xu H.

Cell Mol Immunol. 2010 Jul;7(4):316-22. doi: 10.1038/cmi.2010.7. Epub 2010 Mar 15.

14.

GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells.

Liao G, Nayak S, Regueiro JR, Berger SB, Detre C, Romero X, de Waal Malefyt R, Chatila TA, Herzog RW, Terhorst C.

Int Immunol. 2010 Apr;22(4):259-70. doi: 10.1093/intimm/dxq001. Epub 2010 Feb 5.

15.

Integrating costimulatory agonists to optimize immune-based cancer therapies.

Pardee AD, Wesa AK, Storkus WJ.

Immunotherapy. 2009 Mar;1(2):249-64. doi: 10.2217/1750743X.1.2.249. Review.

16.

Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.

Piao J, Kamimura Y, Iwai H, Cao Y, Kikuchi K, Hashiguchi M, Masunaga T, Jiang H, Tamura K, Sakaguchi S, Azuma M.

Immunology. 2009 Aug;127(4):489-99. doi: 10.1111/j.1365-2567.2008.03036.x.

17.

Sequence, structure, function, immunity: structural genomics of costimulation.

Chattopadhyay K, Lazar-Molnar E, Yan Q, Rubinstein R, Zhan C, Vigdorovich V, Ramagopal UA, Bonanno J, Nathenson SG, Almo SC.

Immunol Rev. 2009 May;229(1):356-86. doi: 10.1111/j.1600-065X.2009.00778.x. Review.

18.

1.8 A structure of murine GITR ligand dimer expressed in Drosophila melanogaster S2 cells.

Chattopadhyay K, Ramagopal UA, Nathenson SG, Almo SC.

Acta Crystallogr D Biol Crystallogr. 2009 May;65(Pt 5):434-9. doi: 10.1107/S0907444909005721. Epub 2009 Apr 18.

19.

Evolution of a new function by degenerative mutation in cephalochordate steroid receptors.

Bridgham JT, Brown JE, Rodríguez-Marí A, Catchen JM, Thornton JW.

PLoS Genet. 2008 Sep 12;4(9):e1000191. doi: 10.1371/journal.pgen.1000191.

20.

Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.

Zhou Z, Song X, Berezov A, Zhang G, Li Y, Zhang H, Murali R, Li B, Greene MI.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5465-70. doi: 10.1073/pnas.0711350105. Epub 2008 Mar 31.

Items per page

Supplemental Content

Write to the Help Desk